Role of triglyceride-rich lipoproteins in diabetic nephropathy.

John C Rutledge, Kit F. Ng, Hnin H. Aung, Dennis W Wilson

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Diabetic nephropathy is an increasingly important cause of morbidity and mortality worldwide. A large body of evidence suggests that dyslipidemia has an important role in the progression of kidney disease in patients with diabetes. Lipids may induce renal injury by stimulating TGF-beta, thereby inducing the production of reactive oxygen species and causing damage to the glomeruli and glomerular glycocalyx. Findings from basic and clinical studies strongly suggest that excess amounts of a variety of lipoproteins and lipids worsens diabetes-associated microvascular and macrovascular disease, increases glomerular injury, increases tubulointerstitial fibrosis, and accelerates the progression of diabetic nephropathy. The increasing prevalence of obesity, type 2 diabetes mellitus, and diabetic nephropathy means that interventions that can interrupt the pathophysiological cascade of events induced by lipoproteins and lipids could enable major life and cost savings. This Review discusses the structural, cellular, and microscopic findings associated with diabetic nephropathy and the influence of lipoproteins, specifically triglyceride-rich lipoproteins (TGRLs), on the development and perpetuation of diabetic nephropathy. Some of the accepted and hypothesized mechanisms of renal injury relating to TGRLs are also described.

Original languageEnglish (US)
Pages (from-to)361-370
Number of pages10
JournalNature reviews. Nephrology
Volume6
Issue number6
DOIs
StatePublished - Jun 2010

Fingerprint

Diabetic Nephropathies
Lipoproteins
Triglycerides
Lipids
Wounds and Injuries
Kidney
Glycocalyx
Cost Savings
Kidney Diseases
Dyslipidemias
Transforming Growth Factor beta
Type 2 Diabetes Mellitus
Reactive Oxygen Species
Fibrosis
Obesity
Morbidity
Mortality

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Role of triglyceride-rich lipoproteins in diabetic nephropathy. / Rutledge, John C; Ng, Kit F.; Aung, Hnin H.; Wilson, Dennis W.

In: Nature reviews. Nephrology, Vol. 6, No. 6, 06.2010, p. 361-370.

Research output: Contribution to journalArticle

@article{ac01398a110841b0b3379f1a5354bff7,
title = "Role of triglyceride-rich lipoproteins in diabetic nephropathy.",
abstract = "Diabetic nephropathy is an increasingly important cause of morbidity and mortality worldwide. A large body of evidence suggests that dyslipidemia has an important role in the progression of kidney disease in patients with diabetes. Lipids may induce renal injury by stimulating TGF-beta, thereby inducing the production of reactive oxygen species and causing damage to the glomeruli and glomerular glycocalyx. Findings from basic and clinical studies strongly suggest that excess amounts of a variety of lipoproteins and lipids worsens diabetes-associated microvascular and macrovascular disease, increases glomerular injury, increases tubulointerstitial fibrosis, and accelerates the progression of diabetic nephropathy. The increasing prevalence of obesity, type 2 diabetes mellitus, and diabetic nephropathy means that interventions that can interrupt the pathophysiological cascade of events induced by lipoproteins and lipids could enable major life and cost savings. This Review discusses the structural, cellular, and microscopic findings associated with diabetic nephropathy and the influence of lipoproteins, specifically triglyceride-rich lipoproteins (TGRLs), on the development and perpetuation of diabetic nephropathy. Some of the accepted and hypothesized mechanisms of renal injury relating to TGRLs are also described.",
author = "Rutledge, {John C} and Ng, {Kit F.} and Aung, {Hnin H.} and Wilson, {Dennis W}",
year = "2010",
month = "6",
doi = "10.1038/nrneph.2010.59",
language = "English (US)",
volume = "6",
pages = "361--370",
journal = "Nature Reviews Nephrology",
issn = "1759-507X",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Role of triglyceride-rich lipoproteins in diabetic nephropathy.

AU - Rutledge, John C

AU - Ng, Kit F.

AU - Aung, Hnin H.

AU - Wilson, Dennis W

PY - 2010/6

Y1 - 2010/6

N2 - Diabetic nephropathy is an increasingly important cause of morbidity and mortality worldwide. A large body of evidence suggests that dyslipidemia has an important role in the progression of kidney disease in patients with diabetes. Lipids may induce renal injury by stimulating TGF-beta, thereby inducing the production of reactive oxygen species and causing damage to the glomeruli and glomerular glycocalyx. Findings from basic and clinical studies strongly suggest that excess amounts of a variety of lipoproteins and lipids worsens diabetes-associated microvascular and macrovascular disease, increases glomerular injury, increases tubulointerstitial fibrosis, and accelerates the progression of diabetic nephropathy. The increasing prevalence of obesity, type 2 diabetes mellitus, and diabetic nephropathy means that interventions that can interrupt the pathophysiological cascade of events induced by lipoproteins and lipids could enable major life and cost savings. This Review discusses the structural, cellular, and microscopic findings associated with diabetic nephropathy and the influence of lipoproteins, specifically triglyceride-rich lipoproteins (TGRLs), on the development and perpetuation of diabetic nephropathy. Some of the accepted and hypothesized mechanisms of renal injury relating to TGRLs are also described.

AB - Diabetic nephropathy is an increasingly important cause of morbidity and mortality worldwide. A large body of evidence suggests that dyslipidemia has an important role in the progression of kidney disease in patients with diabetes. Lipids may induce renal injury by stimulating TGF-beta, thereby inducing the production of reactive oxygen species and causing damage to the glomeruli and glomerular glycocalyx. Findings from basic and clinical studies strongly suggest that excess amounts of a variety of lipoproteins and lipids worsens diabetes-associated microvascular and macrovascular disease, increases glomerular injury, increases tubulointerstitial fibrosis, and accelerates the progression of diabetic nephropathy. The increasing prevalence of obesity, type 2 diabetes mellitus, and diabetic nephropathy means that interventions that can interrupt the pathophysiological cascade of events induced by lipoproteins and lipids could enable major life and cost savings. This Review discusses the structural, cellular, and microscopic findings associated with diabetic nephropathy and the influence of lipoproteins, specifically triglyceride-rich lipoproteins (TGRLs), on the development and perpetuation of diabetic nephropathy. Some of the accepted and hypothesized mechanisms of renal injury relating to TGRLs are also described.

UR - http://www.scopus.com/inward/record.url?scp=77956636092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956636092&partnerID=8YFLogxK

U2 - 10.1038/nrneph.2010.59

DO - 10.1038/nrneph.2010.59

M3 - Article

C2 - 20440276

AN - SCOPUS:77956636092

VL - 6

SP - 361

EP - 370

JO - Nature Reviews Nephrology

JF - Nature Reviews Nephrology

SN - 1759-507X

IS - 6

ER -